COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Article view: 518

Article download: 133

Indian Journal of Clinical and Experimental Ophthalmology

Neuromyelitis optica – A masquerade of multiple sclerosis

Full Text PDF Share on Facebook Share on Twitter

Author Details : Kambam Gainathi, Elfride Farokh Sanjana, Hannah Ranjee Prasanth

Volume : 4, Issue : 2, Year : 2018

Article Page : 287-289

Suggest article by email


We describe a case of neuromyelitis optica - a Masquerade of multiple sclerosis. Neuromyelitis optica should be differentiated from multiple sclerosis, as treatment of multiple sclerosis can worsen symptoms of neuromyelitis optica. Both visual and neurological prognosis in neuromyelitis optica are poorer than in multiple sclerosis. Episodes of visual loss in neuromyelitis optica are recurrent leading to severe visual impairment. Immunosuppressive agents such as corticosteroids remain the mainstay of therapy for acute episodes.

Keywords: Aquaporin-4, Azathioprine, Multiple sclerosis, MRI, Neuromyelitis optica.

Doi : 10.18231/2395-1451.2018.0064

How to cite : Gainathi K, Sanjana E F, Prasanth H R, Neuromyelitis optica – A masquerade of multiple sclerosis. Indian J Clin Exp Ophthalmol 2018;4(2):287-289

Copyright © 2018 by author(s) and Indian J Clin Exp Ophthalmol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (